Liabilities / Assets
29th percentile
Higher debt load relative to assets than 29% of similar nonprofits.
Lmsarcoma Direct Research Foundation
990 • Fiscal year 2020 • EIN 87-0763851
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
30th percentile
Higher debt load relative to revenue than 30% of similar nonprofits.
Net Margin
21st percentile
Higher net margin than 21% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
18th percentile
Faster asset growth than 18% of similar nonprofits.
Revenue Growth
72nd percentile
Faster revenue growth than 72% of similar nonprofits.
Balance Sheet
Assets
Down$584,893
Down $32,360 (-5.2%) from 2019
Net Assets
Down$584,428
Down $32,825 (-5.3%) from 2019
Liabilities
Up$465
Up $465 from 2019
Revenue And Expenses
Revenue
Up$252,428
Up $35,709 (+16%) from 2019
Expenses
Up$285,253
Up $268,883 (+1643%) from 2019
Net Income
Down-$32,825
Down $233,174 (-116%) from 2019
Historical Trend
Filing Detail Status
This 2020 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2020 to Dec 31, 2020
Mission and Program Overview
Mission
To help find a cure for leiomyosarcoma by creating relationships with researchers and funding research that can lead to an effective treatment. To provide a forum for patients and care givers to share there experiences and to keep them informed of current studies.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2020 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $584,893
- Liabilities
- $465
- Net assets
- $584,428
- Revenue
- $252,428
- Expenses
- $285,253
- Net income
- -$32,825